Healthcare
Shoulder Innovations, Inc.(SI)
Live Price
Offline$14.15
-0.91% today
Window Change
-5.98%
Window
Jul 31, 2025 โ Jun 8, 2026
- Market Cap
- $280.00M
- Revenue Growth
- +49.6%
- EPS Growth
- +99.4%
- Dividend Yield
- 0.0%
Coverage: 215 bars ยท Jul 31, 2025 โ Jun 8, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Shoulder Innovations, Inc. (SI) is a Healthcare stock with a market cap of $280.00M and listed on NYSE. The stock last traded around $14.15 and down 6.0% across the available one-year price window (Jul 31, 2025 โ Jun 8, 2026). Baseline metrics include revenue growth of +49.6%, EPS growth of +99.4%, a dividend yield of 0.0%. What stands out right now is revenue +49.6%, EPS +99.4%, free cash flow -98.4% with operating margin -55.6% and ROIC -14.8%. Valuation sits in the middle of the pack at price/sales 5.9. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines SI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+49.6% vs +7.6% peer median
Operating Margin
Below sector median
-55.6% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 7, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +49.6% and EPS at +99.4%, with operating margin around -55.6%.
The next real check-in already has a date
The next earnings event is scheduled for Jul 24, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +22.9% over the next 5 trading days and finished higher after 3 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 7, 2026 | โ | +3.4% | +22.1% | +11.8% |
2026 Mar 10, 2026 | +9.5% | +7.4% | +15.9% | +11.9% |
2025 Nov 11, 2025 | -53.1% | +32.0% | +30.7% | +30.4% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SI
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
SI Max Drawdown
-31.27%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SI and SPY.
Company Overview
Shoulder Innovations, Inc.
New York Stock Exchange
Shoulder Innovations, Inc. manufactures medical devices. It has developed a shoulder replacement system. The company was founded by Stephen B. Gunther and Michael DeVries in 2009 and is headquartered in Grand Rapids, MI.
- Leadership
- Alan J. Lane
- IPO Date
- Jul 31, 2025
- Employees
- 300
- Street Address
- 4250 Executive Square
- Mailing
- La Jolla, CA, 92037
- Region
- La Jolla, CA, US
- Reporting Currency
- USD
- Investor Line
- 858 362 6300
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 5.9
- Price/Book
- 1.8
Growth
- Revenue
- +49.6%
- EPS
- +99.4%
- Free Cash Flow
- -98.4%
Profitability
- Gross Margin
- 76.5%
- Operating Margin
- -55.6%
- Net Margin
- -85.3%
- ROE
- -89.5%
- ROIC
- -14.8%
Balance Sheet
- Debt/Equity
- 0.10
- Current Ratio
- โ
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.